The manufacturing and distribution operations of many pharmaceutical companies are inefficient and outdated. According to a report released Monday, Feb. 21, by PricewaterhouseCoopers US, most pharmaceutical companies are too concerned about new drug discoveries and meeting regulations that they neglect to keep their supply chains functional and up-to-date.
The supply chain comprises all business processes involved in the movement of warehouse supplies and finished products from the manufacturing plant to end users. It includes the manufacturing, warehousing, transportation and distribution of goods and services.
Pharmaceutical supply chains that meet the growing demand and increased complexity of new products and services will become an important means of market differentiation and play an important role in the formulation of business strategies, PwC says.